We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY CLICK HERE
to review a copy of the book
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
SEE MORE
recent work right here
The Medical News
ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.... (Reuters Health) - An age-old nomadic community of Southeast Asian boat-dwellers who get their food from the sea appear to have evolved enlarged spleens that may help explain their extreme diving prowess, a new study suggests.... PARIS/CHICAGO (Reuters) - The World Health Organization (WHO) said on Thursday Sanofi's vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection.... (Reuters Health) - A new study of hundreds of thousands of U.S. armed forces veterans concludes that banging your head severely enough to lose consciousness can dramatically increase the risk of Parkinson's, the brain disease marked by tremors, slow movements, balance problems and difficulty walking.... (Reuters) - An experimental rheumatoid arthritis drug developed by Eli Lilly and Co and Incyte Corp poses serious risks of deadly blood clots at higher doses, U.S. Food and Drug Administration staff said on Thursday, the latest setback to a treatment regulators declined to approve last year.... (Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma.... (Reuters Health) - Following practices recommended for "optimal" heart health may also reduce the risk of developing a serious heart-rhythm disorder, researchers say.... (Reuters) - A federal appeals court on Wednesday blocked an Ohio law that would cut federal taxpayer funding to 28 Planned Parenthood clinics, holding that conditions it imposed that denied funds to abortion providers were unconstitutional.... LONDON, April 18 (Reuters) - Gene-editing technologies that alter mosquitoes' DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should not block progress in such gene-modifying research.... (Reuters) - U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday....